N

Nektar Therapeutics
D

NKTR

24.775
USD
-0.74
(-2.90%)
مغلق
حجم التداول
35,087
الربح لكل سهم
-12
العائد الربحي
-
P/E
-3
حجم السوق
307,381,071
أصول ذات صلة
A
ALKS
-0.200
(-0.69%)
28.790 USD
AMGN
AMGN
1.79
(0.60%)
298.52 USD
BIIB
BIIB
-1.170
(-0.88%)
132.000 USD
BMRN
BMRN
0.560
(0.98%)
57.750 USD
GILD
GILD
-0.760
(-0.68%)
110.760 USD
INCY
INCY
0.300
(0.44%)
68.470 USD
LLY
LLY
0.55
(0.07%)
779.65 USD
MRK
MRK
-1.370
(-1.66%)
81.010 USD
PFE
PFE
0.110
(0.43%)
25.440 USD
REGN
REGN
-0.69
(-0.13%)
546.88 USD
المزيد
الأخبار المقالات

العنوان: Nektar Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.